Background
==========

Serious infections are among the leading causes of hospitalization, morbidity, and mortality in systemic lupus erythematosus (SLE) patients. Patients with lupus nephritis (LN) may be especially vulnerable. We investigated the sociodemographics and epidemiology of serious infections requiring hospitalization in a nationwide cohort of SLE and LN patients enrolled in Medicaid, the US federal-state insurance for low-income individuals.

Methods
=======

We used the Medicaid Analytic eXtract (MAX) data system, with billing claims and demographics for \>24 million Medicaid enrollees from 47 states and Washington, DC, 2000 to 2006. We identified patients aged 18 to 65 years with prevalent SLE (≥3 visits ≥30 days apart with ICD-9 codes of 710.0) and prevalent LN (≥ICD-9 codes for nephritis, proteinuria and/or renal failure on or after SLE diagnosis, ≥30 days apart). We defined serious bacterial, viral, fungal and mycobacterial infections resulting in hospitalization using a validated administrative database method. We stratified infection prevalence in SLE and LN by subtype, sociodemographic factors (age, sex, race/ethnicity, region, socioeconomic status (SES)), and by a validated SLE comorbidity index. We used Poisson regression to calculate incidence rates (cases/person-years) of first and overall infection, stratified by age, sex and race/ethnicity.

Results
=======

We identified 43,274 patients with SLE and 8,096 with LN. Mean age was 38 (SD 12) for SLE and 34 (SD 12) for LN. In the SLE cohort, 93% were female, 38% were Black, 37% White and 15% Hispanic; and in the LN cohort, 89% were female, 48% were Black, 23% White, and 17% Hispanic. We identified 17,055 episodes of serious infections requiring hospitalization in 7,823 SLE patients (28%) and 7,486 episodes in 3,035 LN patients (38%). Among SLE patients, the highest percentages of infections occurred in 35 to 50 year olds, in females, African Americans, in the South and in the lowest SES group (Table [1](#T1){ref-type="table"}). The incidence rates of serious infection per 100 person-years were 15.4 for SLE and 34.5 for LN. In both cohorts, the majority (98%) of infections were bacterial - pneumonia and bacteremia; the most common viral infections were herpes zoster and influenza.

###### 

Serious infections requiring hospitalization in SLE and LN patients, stratified by sociodemographic factors and the SLE comorbidity index

                                                              Prevalent SLE cohort (*n*= 43,274)   Prevalent LN cohort (*n*= 8,096)
  ----------------------------------------------------------- ------------------------------------ ----------------------------------
  Total number of patients with a serious infection, *n*(%)   7,823 (18.1)                         3,035 (37.5)
  Total number of episodes of serious infections              17,055                               7,486
  Age, *n*(%)                                                                                      
    18 to 34                                                  2,738 (35)                           1,489 (49.1)
    35 to 50                                                  3,385 (43.3)                         1,063 (35)
    51 to 65                                                  1,700 (21.7)                         483 (15.9)
  Sex, *n*(%)                                                                                      
    Female                                                    7,211 (92.2)                         2,684 (88.4)
    Male                                                      612 (7.8)                            351 (11.6)
  Race/ethnicity, *n*(%)                                                                           
    White                                                     2,613 (33.4)                         674 (22.2)
    African American                                          3,465 (44.3)                         1,568 (51.7)
    Hispanic                                                  915 (11.7)                           429 (14.1)
    Asian                                                     272 (3.5)                            148 (4.9)
    Native American                                           141 (1.8)                            59 (5.2)
    Other                                                     417 (5.3)                            157 (5.2)
  Region                                                                                           
    Northeast                                                 1,502 (19.2)                         578 (19.0)
    South                                                     3,187 (40.7)                         1,198 (39.5)
    Midwest                                                   1,736 (22.2)                         748 (24.7)
    West                                                      1,398 (17.9)                         511 (16.8)
  SES tertile                                                                                      
    SES 1 (lowest)                                            2,525 (32.3)                         937 (30.9)
    SES 2                                                     2,402 (30.7)                         1,001 (33.0)
    SES 3 (highest)                                           2,441 (31.2)                         935 (30.8)
  SLE specific risk index^a^                                                                       
    Index 1 (lowest)                                          2,298 (29.4)                         1,164 (38.4)
    Index 2                                                   3,478 (44.5)                         864 (28.5)
    Index 3 (highest)                                         2,047 (26.2)                         1,007 (33.2)

^a^SLE-specific modification of the Charlson comorbidity index developed by MM Ward and more predictive of in-hospital mortality than the Charlson index among SLE patients.

Conclusions
===========

In this diverse, nationwide cohort of SLE and LN patients, we observed a significant burden of serious infections requiring hospitalization, most pronounced in LN patients. Further research is necessary to examine risk factors, particularly medication use, by sociodemographic groups.
